M. Davis

780 total citations
20 papers, 648 citations indexed

About

M. Davis is a scholar working on Parasitology, Pharmacology and Molecular Biology. According to data from OpenAlex, M. Davis has authored 20 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Parasitology, 6 papers in Pharmacology and 5 papers in Molecular Biology. Recurrent topics in M. Davis's work include Parasites and Host Interactions (8 papers), Drug-Induced Hepatotoxicity and Protection (6 papers) and Alkaline Phosphatase Research Studies (4 papers). M. Davis is often cited by papers focused on Parasites and Host Interactions (8 papers), Drug-Induced Hepatotoxicity and Protection (6 papers) and Alkaline Phosphatase Research Studies (4 papers). M. Davis collaborates with scholars based in United States, United Kingdom and Sweden. M. Davis's co-authors include Sergio Giralt, Naoto T. Ueno, Richard E. Champlin, Michèle L. Donato, David F. Claxton, Paolo Anderlini, James Gajewski, Börje S. Andersson, Issa F. Khouri and Xuemei Wang and has published in prestigious journals such as Blood, The Journal of Urology and British Journal of Cancer.

In The Last Decade

M. Davis

19 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Davis United States 9 455 179 155 119 94 20 648
Tong Wu China 14 468 1.0× 263 1.5× 253 1.6× 143 1.2× 96 1.0× 66 853
SC Gulati United States 11 284 0.6× 107 0.6× 105 0.7× 48 0.4× 84 0.9× 16 406
C Wheeler United States 12 203 0.4× 343 1.9× 47 0.3× 86 0.7× 209 2.2× 23 686
Nicolaus Kröger Germany 16 401 0.9× 271 1.5× 306 2.0× 77 0.6× 269 2.9× 65 817
Xiujin Ye China 16 526 1.2× 253 1.4× 236 1.5× 130 1.1× 326 3.5× 94 984
Masuji Yamamoto Japan 9 373 0.8× 239 1.3× 162 1.0× 49 0.4× 104 1.1× 19 574
Tiziana Zei Italy 11 706 1.6× 252 1.4× 705 4.5× 104 0.9× 89 0.9× 26 1.1k
Jochen Casper Germany 13 313 0.7× 145 0.8× 75 0.5× 139 1.2× 241 2.6× 39 701
F.W. Busch Germany 11 107 0.2× 98 0.5× 171 1.1× 31 0.3× 124 1.3× 26 499
Gregory Bascug United States 4 294 0.6× 93 0.5× 516 3.3× 24 0.2× 151 1.6× 5 706

Countries citing papers authored by M. Davis

Since Specialization
Citations

This map shows the geographic impact of M. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Davis more than expected).

Fields of papers citing papers by M. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Davis. The network helps show where M. Davis may publish in the future.

Co-authorship network of co-authors of M. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of M. Davis. A scholar is included among the top collaborators of M. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Davis. M. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Yee Chung, Vicente Valero, M. Davis, et al.. (2010). Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients. British Journal of Cancer. 103(9). 1331–1334. 6 indexed citations
2.
Souza, Jonas A. de, M. Davis, Gabriela Rondón, et al.. (2009). Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer. Bone Marrow Transplantation. 44(2). 81–87. 7 indexed citations
4.
Erickson, P.S., et al.. (2004). Ionophore taste preferences of dairy heifers1. Journal of Animal Science. 82(11). 3314–3320. 16 indexed citations
6.
Ravandi, Farhad, Hagop M. Kantarjian, A Cohen, et al.. (2001). Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study. Bone Marrow Transplantation. 27(12). 1221–1225. 33 indexed citations
8.
Giralt, Sergio, M. Davis, Susan O’Brien, et al.. (1997). Studies of decitabine with allogeneic progenitor cell transplantation.. PubMed. 11 Suppl 1. S32–4. 13 indexed citations
9.
Crawford, E. David, David R. McKenzie, Wiking Månsson, et al.. (1986). Adverse Reactions to the Intravesical Administration of Doxorubicin Hydrochloride: Report of 6 Cases. The Journal of Urology. 136(3). 668–669. 19 indexed citations
10.
Neuberger, James, Bernard Portmann, H.B. Nunnerley, et al.. (1980). Oral-Contraceptive-Associated Liver Tumours Occurrence of Malignancy and Difficulties in Diagnosis. Obstetrical & Gynecological Survey. 35(8). 518–520. 1 indexed citations
11.
Davis, M., et al.. (1969). Nitroxynil - the development of a new fasciolicide.. 33. 25–32. 1 indexed citations
12.
Davis, M., et al.. (1968). The chemotherapy of schistosomiasis. Part IX. p-Dialkylaminoacylamidophenyl ethers. Journal of the Chemical Society C Organic. 1. 61–61. 1 indexed citations
13.
Davis, M., et al.. (1966). The chemotherapy of schistosomiasis. Part VI. Ethers of 4-amino-catechol and 4-aminoresorcinol. Journal of the Chemical Society C Organic. 366–366. 2 indexed citations
14.
Davis, M., et al.. (1966). The chemotherapy of schistosomiasis. Part VIII. 2-Carboxy- and 2-carbamoyl-4-aminophenyl ethers. Journal of the Chemical Society C Organic. 23. 2196–2196. 2 indexed citations
15.
Cosgrove, G. E., M. Davis, & Makoto Asano. (1965). Oncogenic effects of 4-(p-dimethylaminostyryl)quinoline (4m20) in mice.. PubMed. 25(7). 939–45. 1 indexed citations
16.
Davis, M.. (1962). 34. The chemotherapy of schistosomiasis. Part V. Cholesteryl and choloyl derivatives of 4-amino-2-methoxyphenyl ethers. Journal of the Chemical Society (Resumed). 178–178. 8 indexed citations
17.
Davis, M., et al.. (1961). 363. The chemotherapy of schistosomiasis. Part IV. Some ethers of 4-amino-2-methoxyphenol. Journal of the Chemical Society (Resumed). 1863–1863. 13 indexed citations
18.
Ashley, J. N., et al.. (1959). 783. The chemotherapy of schistosomiasis. Part III. N-p-aminophenoxyalkyl-amides, -imides, and -sulphonamides. Journal of the Chemical Society (Resumed). 3880–3880. 1 indexed citations
19.
Ashley, J. N., et al.. (1959). 183. The chemotherapy of schistosomiasis. Part II. Some ethers of p-aminophenol. Journal of the Chemical Society (Resumed). 897–897. 4 indexed citations
20.
Ashley, J. N., et al.. (1958). 673. The chemotherapy of schistosomiasis. Part I. Derivatives and analogues of αω-di-(p-aminophenoxy)alkanes. Journal of the Chemical Society (Resumed). 0(0). 3298–3313. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026